A study provides significant evidence in the field of advanced cardiac imaging and clinical cardiology. It shows that the ...
Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Left ventricular hypertrophy (LVH) is when the heart’s main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart ...
Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Heart failure happens when the heart can’t pump enough blood throughout the body.Chronic heart failure often happens because of other medical ...
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...
End-stage heart failure is increasingly treatable with advanced therapies like LVADs and heart transplantation, offering ...
In acute myocarditis, elevated septal ECV on CMR may help identify advanced AV block and higher-risk patients. Find out more.
Heart failure with preserved ejection fraction (HFpEF) is a condition in which the heart does not fill with blood properly. In HFpEF, the heart can pump normally, but the heart is stiff and cannot ...